Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Rousseau

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Clinical Nuclear Medicine|May 29, 2015
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate CancerAurore Goineau, Mathilde Colombié, Caroline Rousseau, et al.
Oncogene|May 31, 2003
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathwaySonia V del Rincón, Caroline Rousseau, Ratna Samanta, et al.
Blood|February 15, 2003
Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cellsMichael Witcher, Douglas T Ross, Caroline Rousseau, et al.
Expert Review of Anticancer Therapy|August 1, 2012
New frontiers in therapeutic resistance in cancerAndrea Sartore-Bianchi, Mauro Delorenzi, Thérèse Gagnon-Kugler, et al.
Clinical Nuclear Medicine|December 13, 2018
68Ga-PSMA PET/CT Urachus Metastases in Recurrent Prostate Cancer With Very Low PSA LevelMaëlle Le Thiec, Daniela Rusu, Vincent Fleury, et al.
Frontiers in Medicine|June 1, 2016
Quantitative Evaluation of Therapeutic Response by FDG-PET-CT in Metastatic Breast CancerDorothée Goulon, Hatem Necib, Brice Henaff, et al.
Molecular Cancer Research : MCR|September 24, 2004
ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalkCaroline Rousseau, Jessica N Nichol, Filippa Pettersson, et al.
Frontiers in Pharmacology|March 14, 2013
Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisitedLee Black, Gerald Batist, Denise Avard, et al.
BMC Medical Ethics|December 11, 2012
Recruiting terminally ill patients into non-therapeutic oncology studies: views of health professionalsErika Kleiderman, Denise Avard, Lee Black, et al.
Cancers|March 29, 2023
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed TherapyRaphaël Metz, Aurore Rauscher, Loïg Vaugier, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Clinical Nuclear Medicine|May 29, 2015
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate CancerAurore Goineau, Mathilde Colombié, Caroline Rousseau, et al.
Oncogene|May 31, 2003
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathwaySonia V del Rincón, Caroline Rousseau, Ratna Samanta, et al.
Blood|February 15, 2003
Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cellsMichael Witcher, Douglas T Ross, Caroline Rousseau, et al.
Expert Review of Anticancer Therapy|August 1, 2012
New frontiers in therapeutic resistance in cancerAndrea Sartore-Bianchi, Mauro Delorenzi, Thérèse Gagnon-Kugler, et al.
Clinical Nuclear Medicine|December 13, 2018
68Ga-PSMA PET/CT Urachus Metastases in Recurrent Prostate Cancer With Very Low PSA LevelMaëlle Le Thiec, Daniela Rusu, Vincent Fleury, et al.
Frontiers in Medicine|June 1, 2016
Quantitative Evaluation of Therapeutic Response by FDG-PET-CT in Metastatic Breast CancerDorothée Goulon, Hatem Necib, Brice Henaff, et al.
Molecular Cancer Research : MCR|September 24, 2004
ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalkCaroline Rousseau, Jessica N Nichol, Filippa Pettersson, et al.
Frontiers in Pharmacology|March 14, 2013
Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisitedLee Black, Gerald Batist, Denise Avard, et al.
BMC Medical Ethics|December 11, 2012
Recruiting terminally ill patients into non-therapeutic oncology studies: views of health professionalsErika Kleiderman, Denise Avard, Lee Black, et al.
Cancers|March 29, 2023
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed TherapyRaphaël Metz, Aurore Rauscher, Loïg Vaugier, et al.
Pageof 12